Financhill
Back

Prysmian SpA Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
65

PRYMY
Prysmian SpA

Last Price:
32.75
Seasonality Move:
5.26%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.50
Seasonality Move:
14.88%
Buy
65
Prysmian SpA (PRYMY) is a Buy

Is Prysmian SpA a Buy, Sell or Hold?

  • The current Prysmian SpA [PRYMY] share price is $32.53. The Score for PRYMY is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • PRYMY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRYMY Stock Price Chart

What is Prysmian SpA's stock price today?

  • The Prysmian SpA share price today is $32.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRYMY is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

PRYMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.83 Sell
Relative Strength Index (14 RSI): 41.33 Sell
Chaikin Money Flow: 47295 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.25 - 35.55) Sell
Bollinger Bands (100): (32.73 - 35.89) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

PRYMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.24 Buy
20-day SMA: 33.26 Sell
50-day SMA: 35.03 Sell
200-day SMA: 31.19 Buy
8-day EMA: 32.5 Buy
20-day EMA: 33.24 Sell
50-day EMA: 34.08 Sell
200-day EMA: 31.18 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Prysmian SpA Earnings Growth & PRYMY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Prysmian SpA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):